Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges
Yunlong Shan,
No information about this author
Mengying Zhang,
No information about this author
Enxiang Tao
No information about this author
et al.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Sept. 13, 2024
Language: Английский
Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus
Le Dai,
No information about this author
Qing Wang
No information about this author
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 4, 2025
Abstract
Type
1
diabetes
mellitus
(T1DM)
is
characterized
by
progressive
β-cell
death,
leading
to
loss
and
insufficient
insulin
secretion.
Mesenchymal
stem
cells
(MSCs)
transplantation
currently
one
of
the
most
promising
methods
for
replacement
therapy.
However,
recent
studies
have
shown
that
ferroptosis
not
only
key
mechanisms
but
also
reasons
extensive
cell
death
within
a
short
period
time
after
MSCs
transplantation.
Ferroptosis
new
type
regulated
(RCD)
iron-dependent
accumulation
lipid
peroxides.
Due
weak
antioxidant
capacity
β-cells,
they
are
susceptible
cytotoxic
stimuli
such
as
oxidative
stress
(OS),
therefore
ferroptosis.
Transplanted
extremely
perturbations
in
their
microenvironment,
especially
OS,
which
can
weaken
induce
through
In
pathophysiological
process
T1DM,
large
amount
reactive
oxygen
species
(ROS)
produced,
causing
OS.
Therefore,
targeting
may
be
way
protect
β-cells
improve
therapeutic
effect
This
review
reviews
research
related
MSCs,
summarizes
developed
strategies
help
inhibit
study
aims
understand
mechanism
transplantation,
emphasize
importance
protecting
improving
survival
function
transplanted
provide
direction
therapy
T1DM
future.
Language: Английский
MSC-EV-transmitted HSPA8 alleviates cisplatin-induced ovotoxicity by regulating the MGARP/PRDX2 axis
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 140973 - 140973
Published: Feb. 1, 2025
Language: Английский
The promise of mesenchymal stromal/stem cells in erectile dysfunction treatment: a review of current insights and future directions
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 26, 2025
Erectile
dysfunction
is
a
common
and
multifactorial
condition
that
significantly
impacts
men's
quality
of
life.
Traditional
treatments,
such
as
phosphodiesterase
type
5
inhibitors
(PDE5i),
often
fail
to
provide
lasting
benefits,
particularly
in
patients
with
underlying
health
conditions.
In
recent
years,
regenerative
medicine,
stem
cell
therapies,
has
emerged
promising
alternative
for
managing
erectile
dysfunction.
This
review
explores
the
potential
mesenchymal
stromal/stem
cells
(MSCs)
their
paracrine
effects,
including
extracellular
vesicles
(EVs),
treatment
MSCs
have
shown
remarkable
promoting
tissue
repair,
reducing
inflammation,
regenerating
smooth
muscle
cells,
offering
therapeutic
benefits
models
Clinical
trials
demonstrated
positive
outcomes
improving
function
other
clinical
parameters.
highlights
promise
MSC
therapy
dysfunction,
discusses
existing
challenges,
emphasizes
need
continued
research
refine
these
therapies
improve
long-term
patient
outcomes.
Language: Английский
Enzymatic Oxidants, Antioxidants, and Inflammatory Bowel Disease
Applied Biosciences,
Journal Year:
2025,
Volume and Issue:
4(2), P. 19 - 19
Published: April 1, 2025
The
role
of
oxidants
and
antioxidants
in
inflammatory
bowel
disease
(IBD)
has
been
actively
explored
since
the
early
1980s,
starting
with
respiratory
burst
neutrophils
ischemia
pathology.
Since
that
time,
enzymatic
components
contributing
to
pool
reactive
oxygen
species,
including
superoxide,
H2O2,
lipid
hydroperoxides,
counteracting
antioxidants—catalase,
glutathione
peroxidases
(Gpx),
peroxiredoxins
(PRDX),
superoxide
dismutases,
others—have
fleshed
out.
My
perspective
on
IBD
is
from
balance
or
imbalance
oxidant
sources
process.
I
will
present
evidence
involvement
antioxidant
processes
based,
as
much
possible,
my
experiences
Gpxs.
This
be
discussed
terms
both
immune
system
local
systems.
As
Gpxs
are
generally
selenium-dependent,
possible
deficiencies
selenium
uptake
active
impact
Gpx
expression
explored.
more
recently
introduced
ferroptosis,
an
iron-dependent
peroxidation-based
pathological
process,
reviewed
for
its
IBD.
Language: Английский
An update on the use of stem cell therapy for erectile dysfunction
Mohamad Abou Chakra,
No information about this author
Hugo Bailly,
No information about this author
Fabian Klampke
No information about this author
et al.
Asian journal of urology,
Journal Year:
2024,
Volume and Issue:
11(4), P. 530 - 544
Published: March 11, 2024
The
objective
of
this
systematic
review
was
to
analyze
animal
and
human
trial
data
better
understand
the
efficacy
stem
cell
therapy
(SCT)
for
erectile
dysfunction
(ED)
obstacles
that
may
encounter
its
application
in
field.
We
searched
electronic
databases,
including
PubMed
Scopus,
published
studies
with
Medical
Subject
Heading
(MeSH)
"erectile
dysfunction"
(AND)
"stem
therapy"
(OR)
dysfunction'
"clinical
"sexual
dysfunction".
search
limited
English-language
journals
full
papers
only.
initial
resulted
450
articles,
which
90
relevant
our
aims
were
included
analysis.
ED
is
a
multifactorial
disease.
Current
treatment
options
rely
on
pharmacotherapy
as
well
surgical
options.
Patients
have
side
effects
or
unsatisfactory
results
following
use
these
SCT
restore
pathophysiological
changes
leading
rather
than
treating
symptoms.
It
has
been
evaluated
models
shown
promising
humans.
Results
confirm
does
improve
function
animals
different
types
SC
use.
In
humans,
evidence
showed
results,
but
trials
heterogeneous
mainly
by
lack
randomization
small
sample
size.
Many
challenges
could
limit
future
research
field,
ethical
dilemmas,
regulation,
patient
recruitment,
cost
therapy,
standardized
regimen.
Repairing
possibly
replacing
diseased
cells,
tissues,
organs
eventually
retrieving
normal
should
always
be
goals
any
can
only
guaranteed
SCT.
potential
successful
ED,
particularly
patients
who
are
resistant
classic
therapy.
promote
nerve
regeneration
vascular
regeneration,
not
symptomatic
treatment.
Language: Английский
Efficacy of adipose‐derived mesenchymal stem cell therapy in the treatment of chronic micro‐ and macrovascular complications of diabetes
Diabetes Obesity and Metabolism,
Journal Year:
2023,
Volume and Issue:
26(3), P. 793 - 808
Published: Dec. 11, 2023
Abstract
Diabetes
mellitus
is
a
highly
prevalent
disease
characterized
by
hyperglycaemia
that
damages
the
vascular
system,
leading
to
micro‐
(retinopathy,
neuropathy,
nephropathy)
and
macrovascular
diseases
(cardiovascular
disease).
There
are
also
secondary
complications
of
diabetes
(cardiomyopathy,
erectile
dysfunction
or
diabetic
foot
ulcers).
Stem
cell‐based
therapies
have
become
promising
tool
targeting
symptoms
its
chronic
complications.
Among
all
stem
cells,
adipose‐derived
mesenchymal
cells
(ADMSCs)
great
importance
because
their
abundance,
non‐invasive
isolation
no
ethical
limitations.
Characteristics
make
ADMSCs
good
candidates
for
therapy
wide
immunomodulatory
properties
paracrine
activities
through
secretion
an
array
growth
factors,
chemokines,
cytokines,
angiogenic
factors
anti‐apoptotic
molecules.
Besides,
after
transplantation,
show
ex
vivo
expansion
capacity
differentiation
other
cell
types,
including
insulin‐producing
cardiomyocytes,
chondrocytes,
hepatocyte‐like
neurons,
endothelial
photoreceptor‐like
astrocytes.
Preclinical
studies
shown
ADMSC‐based
effectively
improved
visual
acuity,
ameliorated
polyneuropathy
ulceration,
arrested
development
progression
kidney
disease,
alleviated
diabetes‐induced
cardiomyocyte
hypertrophy.
However,
despite
positive
results
obtained
in
animal
models,
there
still
several
challenges
need
be
overcome
before
preclinical
can
translated
into
clinical
applications.
To
date,
trials
ongoing
using
treatment
complications,
most
them
ulcers.
This
narrative
review
summarizes
recent
outcomes
on
usage
long‐term
both
models
trials.
Language: Английский
Transcriptomic profiling of human granulosa cells between women with advanced maternal age with different ovarian reserve
Zhi-Cheng Jia,
No information about this author
Yongqian Li,
No information about this author
Bowen Zhou
No information about this author
et al.
Journal of Assisted Reproduction and Genetics,
Journal Year:
2023,
Volume and Issue:
40(10), P. 2427 - 2437
Published: Aug. 17, 2023
Abstract
Background
Age-related
diminished
ovarian
reserve
(DOR)
is
not
absolute.
Some
advanced
maternal
age
(AMA)
still
have
normal
(NOR)
and
often
show
better
pregnancy
outcomes.
Exploring
the
transcriptomic
profile
of
granulosa
cells
(GCs)
in
AMA
could
lead
to
new
ideas
for
mitigating
age-related
reserve.
Aim
This
study
aimed
analyze
GCs
with
different
Results
In
total,
6273
statistically
significant
differential
expression
genes
(DEGs)
(|log2fc|>
1,
q
<
0.05)
were
screened
from
two
groups,
among
which
3436
upregulated,
2837
downregulated
DOR
group.
Through
Gene
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
pathway
enrichment
analysis,
potential
functions
dysregulated
or
NOR
predicted.
The
GO
analysis
revealed
that
DEGs
mainly
enriched
obsolete
oxidation–reduction
process,
mitochondrion,
metal
ion
binding,
ATP
etc.
KEGG
above-mentioned
ferroptosis,
regulation
actin
cytoskeleton,
oxidative
phosphorylation,
Meanwhile,
verification
mRNA
levels
possible
involvement
“ferroptosis”
Conclusions
From
a
clinical
perspective,
we
presented
first
data
showing
between
At
same
time,
identified
role
ferroptosis
AMA,
providing
biological
basis
studying
aging
improving
outcomes
AMA.
Language: Английский
Mitochondria-Rich Microvesicles Alleviate CNI ED by Transferring Mitochondria and Suppressing Local Ferroptosis
Zhenkang Liang,
No information about this author
Zehong Chen,
No information about this author
Chaowei Zhang
No information about this author
et al.
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 11745 - 11765
Published: Nov. 1, 2024
Erectile
dysfunction
(ED)
frequently
arises
as
a
complication
of
pelvic
surgeries,
including
rectal
and
prostate
surgery,
has
no
definitive
cure.
This
study
explored
whether
mitochondria-rich
microvesicles
(MVs)
can
be
used
to
treat
ED
stemming
from
cavernous
nerve
injury
(CNI)
investigated
its
potential
mechanisms.
We
isolated
MVs
mitochondria
(MT)
PC12.
The
apoptosis
rate,
mitochondrial
membrane
(MMP),
reactive
oxygen
species
(ROS),
derived
(mtROS),
iron
content,
malondialdehyde
(MDA)
content
endogenous
antioxidant
system
activity
corpus
cavernosum
smooth
muscle
cells
(CCSMCs)
cultured
with
MT
were
detected
in
vitro.
In
vivo,
twenty-four
male
Sprague
Dawley
rats
randomly
divided
into
four
groups:
sham
operation
group
CNI
injected
PBS,
respectively.
After
fourteen
days
treatment,
the
erectile
function
was
measured
penile
tissues
collected
for
histological
analysis.
Subsequently,
inhibition
MV
performed
explore
mechanism
rescue
experiment.
CCSMCs,
PC12-MVs
PC12-MT
successfully
identified.
culture,
ROS,
mtROS,
MDA
CCSMCs
significantly
decreased,
while
MMP
activities
increased.
transplantation
restore
CNIED
rats.
experiment
suggested
that
exerted
above
therapeutic
effect
by
transferring
within
it.
improve
may
play
role
anti-OS
anti-ferroptosis
at
transplant
site
through
efficient
transfer
mitochondria,
providing
treatment
vehicle
ED.
Language: Английский
Magnetic soft microrobots for erectile dysfunction therapy
Proceedings of the National Academy of Sciences,
Journal Year:
2024,
Volume and Issue:
121(49)
Published: Nov. 18, 2024
Erectile
dysfunction
(ED)
is
a
major
threat
to
male
fertility
and
quality
of
life,
mesenchymal
stromal
cells
(MSCs)
are
promising
therapeutic
option.
However,
outcomes
compromised
by
low
MSC
retention
survival
rates
in
corpus
cavernosum
tissue.
Here,
we
developed
an
innovative
magnetic
soft
microrobot
comprising
ultrasoft
hydrogel
microsphere
embedded
with
nanoparticle
chain
for
delivery.
This
design
also
features
phenylboronic
acid
groups
scavenging
reactive
oxygen
species
(ROS).
With
Young’s
modulus
less
than
1
kPa,
the
adapts
its
shape
within
narrow
blood
vessels,
ensuring
uniform
distribution
MSCs
cavernosum.
Our
findings
showed
that
compared
traditional
injections,
delivery
(MSC-Rob)
significantly
enhanced
survival.
In
both
rat
beagle
ED
models,
MSC-Rob
treatment
accelerated
repair
tissue
restored
erectile
function.
Single-cell
RNA
sequencing
(scRNA-seq)
revealed
facilitates
nerve
vessel
regeneration
increasing
presence
regenerative
macrophages.
Overall,
our
not
only
advances
clinical
application
therapy
but
broadens
scope
microrobots
other
cell
therapies.
Language: Английский